http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112592351-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112592351-B |
| titleOfInvention | Eleusine indica trilactone A, medicine for treating Alzheimer disease, preparation method and application |
| abstract | The invention provides a gooseberry trilactone A, a medicine for treating Alzheimer disease, a preparation method and application, and belongs to the technical field of medicines; the tinospora edulis trilactone A disclosed by the invention can influence the metabolic pathway of Amyloid Precursor Protein (APP), can reduce the expression capacity of beta-amyloid A beta 42 and A beta 40, can promote the conversion of APP to a non-A beta metabolic pathway, shows a certain capacity of resisting the generation of beta-amyloid A beta, and has the activity of preventing and treating the Alzheimer's disease. |
| priorityDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 346.